(19)
(11) EP 4 798 184 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24798385.1

(22) Date of filing: 21.10.2024
(51) International Patent Classification (IPC): 
A61K 31/34(2006.01)
A61K 31/497(2006.01)
A61K 45/06(2006.01)
A61K 31/443(2006.01)
A61K 31/506(2006.01)
A61P 31/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/34; A61K 31/443; A61K 31/506; A61K 31/497; A61P 31/04; A61K 45/06
 
C-Sets:
  1. A61K 31/34, A61K 2300/00;
  2. A61K 31/443, A61K 2300/00;
  3. A61K 31/506, A61K 2300/00;
  4. A61K 31/497, A61K 2300/00;

(86) International application number:
PCT/AT2024/060416
(87) International publication number:
WO 2025/081213 (24.04.2025 Gazette 2025/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 21.10.2023 AT 601962023

(71) Applicant: ARIVA Med GmbH
1110 Wien (AT)

(72) Inventor:
  • PAUKNER, Susanne
    1160 Wien (AT)

(74) Representative: Schwarz & Partner Patentanwälte GmbH 
Patentanwälte Wipplingerstraße 30
1010 Wien
1010 Wien (AT)

   


(54) NOVEL USES OF 12-EPI-MUTILIN COMPOUNDS